Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hib Capsular Polysaccharide Conjugated to Carrier Protein (Hib conjugate vaccine)
- Target
- Hib conjugate vaccine
- Molecular classification
- Vaccine, Conjugate Vaccine, Polysaccharide
01
Overview
The Hib Capsular Polysaccharide Conjugated to Carrier Protein is a vaccine composed of the polyribosylribitol phosphate (PRP) capsular polysaccharide from *Haemophilus influenzae* type b, chemically conjugated to a carrier protein (e.g., tetanus toxoid, diphtheria toxoid (CRM197), or meningococcal outer membrane protein). This conjugation transforms the poorly immunogenic polysaccharide into a highly effective antigen, especially in infants and young children, stimulating T-cell dependent immunity, robust antibody production, and immunologic memory.
- Other names
- PRP-conjugate vaccineHaemophilus influenzae type b vaccineHib vaccine
02
Mechanism of action
Induces T-cell dependent immune response, leading to B-cell activation, antibody production, and long-term immunological memory against the Hib capsular polysaccharide (PRP).
03
Biological functions
Adaptive immunity inductionB cell activationAntibody productionImmunological memory formationPrevention of infection
04
Disease associations
Prevention of Haemophilus influenzae type b infectionsPrevention of meningitisPrevention of epiglottitisPrevention of pneumoniaPrevention of sepsis
05
Safety considerations
Local injection site reactionsFeverAllergic reactions (rare)Hypersensitivity to vaccine components
06
Biomarkers
Anti-PRP antibody titersSeroconversion rate
Beyond the preview
Go deeper on Hib Capsular Polysaccharide Conjugated to Carrier Protein (Hib conjugate vaccine).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hib Capsular Polysaccharide Conjugated to Carrier Protein (Hib conjugate vaccine).